1. Brannagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996;47:674–677. 2. Silbert PL, Knezevic WV, Bridge DT. Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis. Neurology 1992;42:257–258. 3. Woodruff RK, Grigg AP, Firkin FC, Smith IL. Fatal thrombotic events during tre...

Myasthenic crisis is a life-threatening condition. At times it manifests as the initial presentation of underlying myasthenia gravis. Rapidly acting therapies for treatment this condition are plasma exchange and intravenous immunoglobulin. We report case myasthenic in young female, presenting with respiratory failure bulbar symptoms. She had significantly raised titres anti-acetylcholine recept...

1. Kumar A, Teuber SS, Gershwin ME. Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol. 2006:140:185-98. 2. Fergusson D, Hutton B, Sharma M, Tinmouth A, Wilson K, Cameron DW, Hebert PC. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Transfusion (Paris). 2005:45:1640-57. 3. Dalakas MC. Intravenous immune globulin the...

A 26-year-old, 17-week pregnant woman developed aquaporin-4-IgG-positive severe longitudinally extensive transverse myelitis during the course of disseminated herpes zoster and became quadriparetic. She was unresponsive to high-dose intravenous methylprednisolone but became able to walk without assistance after intravenous immunoglobulin. One and a half months later, left optic neuritis develop...

Abstract Background Here, we report an atypical HIV-vacuolar myelopathy and search the available medical literature about presentations of human immunodeficiency virus associate vacuolar (HIV-VM) immunoglobulin therapy response. Case A 26-year-old lady who was 4 weeks postpartum presented to us with acute flaccid quadriparesis, no sensory level. Extensive workup ruled out other causes myelopath...

OBJECTIVES Clostridium difficile diarrhoea (CDD) cases treated with intravenous immunoglobulin during a 2 year period were reviewed to determine disease severity and response to treatment. PATIENTS AND METHODS Of 580 CD cytotoxin-positive patients, five received intravenous immunoglobulin because of protracted and/or recurrent CDD (median duration 50 days, range 45-64); two had biopsy- proven...

OBJECTIVE The objective of the study was to examine placental histopathology in intravenous immunoglobulin-treated and untreated neonatal alloimmune thrombocytopenia and correlate pathological findings with clinical outcomes. STUDY DESIGN Placentas from 14 neonatal alloimmune thrombocytopenia-affected pregnancies were identified. Maternal antepartum treatment with intravenous immunoglobulin a...

acute hemorrhagic leukoencephalitis (ahle) is a rare demyelinating disease characterized by an acute rapidly progressive fulminant inflammation of the white matter. in this case report, we introduce a case of ahle in children with an interesting and lengthy process and successful treatment. a previously healthy 13-year-old girl was admitted to the hospital because of fever and loss of conscious...

Fresh frozen plasma and intravenous immunoglobulin are used as prophylaxis against, and for the treatment of, neonatal infection. It is assumed that any beneficial effect is mediated through the humoral immune factors contained in each preparation. The effect of fresh frozen plasma and intravenous immunoglobulin on humoral immune markers (immunoglobulins and IgG subclasses, complement component...

Since they were first administered to patients with antibody deficiency disorders over 50 years ago, human intravenous immunoglobulin preparations have been used successfully to treat a rapidly increasing number of autoimmune and inflammatory disorders, among which are a series of cutaneous autoimmune and inflammatory diseases. These include dermatomyositis, Kawasaki's disease, a number of auto...